Distribuția conform vârstei a determinat predominarea copiilor din grupul 5-9 ani cu 21 (35%) şi urmat de 1-4 ani 17 (28%) şi de grupul 5-18 cu 11 (18%) copii. Factorii de risc care conferă sociovulnerbalitate au fost determinaţi la 40 (66%). Din focar tuberculos au provenit 40 (67%). Au fost imunizaţi la naştere, prin vaccinarea BCG, 55 (92%). Depistaţi prin screeningul grupurilor cu risc sporit de îmbolnăvire au fost 20 (33%) copii iar prin investigarea pacientului simptomatic – 40 (60%) copii. Comorbidităţile au fost diagnosticate la 55 (91%) copii, inclusiv anemia feriprivă – 28 (47%), parazitozele intestinale – 20 (33%), boli ale apratului respirator superior – 5 (8%), boli cronice ale tractului genitourinar – 2 (3%), sindromul de consumpţie – 2 (3%), malformaţii congenitale – 2 (3%), paralizia cerebrală infantilă – 2 (3%), tumori – 1 (1,7%), diabet zaharat tip 1 – 1 (1,7%), miodistrofia – 1 (1,7%), infecţii virale – 2 (3%) şi infecţia HIV/SIDA s-a diagnosticat la 1 pacient (1,7%).

The distribution according to the age was identified the predominance of children from the group of 5-9 age with 21 cases (35%), followed by the 17 cases (28%) of 1 and 4 years and the group of 11 (18%) children with 5-18 years. Risk factors which determined the social vulnerbality were estabalished in 40 children (66%). From a tuberculosis focus came 40 (67%) cases. Were vaccinated by BCG at the birth 55 (92%) patients. Detected by the high risk group screening were 20 (33%) children and through the investigation of the simptomatic cases 40 (60%) children. Comorbidities were diagnosed in 55 children (91%), including anemia – 28 (47%), intestinal parasitosis – 20 (33%), chronic respiratory diseases – 5 (8%), chronic genito-urinary diseases – 2 (3%), consumption syndrome – 2 (3%) cases, congential malformation – 2 (3%), cerebral paralisia – 2 (3%) cases, cancer – 1 (1.7%) case, diabetes mellitus type 1 – 1 (1.7%), miodistrophie – 1 (1.7%), viral infections – 2 (3%) and HIV/SIDA infection was diagnosed in 1 patient (1.7%).